As an FP&A Data Analyst Intern, you will help turn data into clear, reliable insights for the teams supporting Novo Nordisk’s portfolio. You will maintain and improve existing dashboards, automate recurring reporting processes, and help ensure that the information used for decision-making is accurate and accessible. Your work will enable colleagues to spend less time preparing data and more time understanding performance and taking action.
You will support the Financial Planning & Analysis (FP&A) team across forecasting, monthly closing, and performance reporting. Your responsibilities will include:
Hands-on experience gained through coursework, personal projects, student organisations, competitions, or previous internships in at least one of the following areas:
You will join the FP&A team, which plans, forecasts, and reports financial performance while partnering with commercial and other business functions to turn numbers into actionable insight. You will work closely with colleagues who use dashboards and reports for planning, monthly closing, and performance reviews, as well as with stakeholders responsible for the underlying data. The role reports to the FP&A Manager in Indonesia.
You will work on real reporting and analytics solutions used by the business. You will have room to take ownership, contribute ideas, build practical skills in data analytics and automation, and learn how FP&A supports business decisions. Clear expectations, regular guidance, and constructive feedback will support your development throughout the internship.
If you are ready to turn data into practical solutions and help improve the way FP&A works, apply for the FP&A Data Analyst Intern role by 25 November 2026. Applications will be reviewed on an ongoing basis, so we encourage you to apply as early as possible.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html